Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Discover the hidden inflammation in psoriasis patients' intestines, its link to leaky gut, and the increased risk of Crohn's ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Medically reviewed by Brendan Camp, MD Psoriasis affects about 3% of all adults in the United States, and Asian Americans ...

Out of more than 3,000 skin diseases, how do you know what condition you have? These 23 skin rash pictures and expert tips ...

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...

Humira may increase the risk of severe infection or malignancy ... and skin cancer. It can take time for psoriasis symptoms to improve, but some therapies have been shown to work faster than others.